MWM
ABBV icon

Moran Wealth Management’s AbbVie ABBV Stock Holding History

Moran Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,718
Closed -$501K – 368
2023
Q2 		$501K Sell
3,718
-1,199
-24% -$176K 0.02% 304
2023
Q1 		$784K Sell
4,917
-128,986
-96% -$19.7M 0.03% 272
2022
Q4 		$21.6M Buy
+133,903
New +$20.5M 0.82% 28

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moran Wealth Management's ABBV Position: Q3 2023 in Review

Moran Wealth Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 3,718 shares — an estimated $501K sold.

Moran Wealth Management first reported a position in ABBV in Q4 2022 and held it in 3 quarters. The position peaked at $21.6M in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Moran Wealth Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Moran Wealth Management sold 3,718 AbbVie shares in Q3 2023, an estimated $501K.
  • Moran Wealth Management first reported a position in AbbVie in Q4 2022 and held it in 3 quarters.
  • Moran Wealth Management's AbbVie position peaked at $21.6M in Q4 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Moran Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.